Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Language
Publication year range
1.
Arq. bras. oftalmol ; Arq. bras. oftalmol;82(2): 111-118, Mar.-Apr. 2019. tab, graf
Article in English | LILACS | ID: biblio-989391

ABSTRACT

ABSTRACT Purpose: To assess the efficacy of using a nonste­roidal anti-inflammatory drug preoperatively and of applying the re-dilation technique when necessary to minimize pupil size variation when comparing the degree of mydriasis before femtosecond laser pretreatment with that at the beginning of phacoemulsification. Methods: This retrospective study included patients who underwent cataract surgery using the LenSx (Alcon Laboratories, Inc., Fort Worth, TX). Our routine dilating regimen with flurbiprofen, tropicamide, and phenylephrine was used. The re-dilation technique was applied on eyes that manifested with a pupillary diameter that was smaller than the programmed capsulotomy diameter after laser pretreatment. The technique consists of overcoming pupillary contraction by instilling tropicamide and phenylephrine before phacoemulsification. Pupil size was assessed before femtosecond laser application and at the beginning of phacoemulsification. Results: Seventy-five eyes (70 patients) were included. Nine (12%) eyes underwent the re-dilation technique. There was no significant difference in mean pupillary diameter and mean pupillary area between the two studied surgical time points (p=0.412 and 0.437, respectively). The overall pupillary area constriction was 2.4 mm2. Immediately before opening the wounds for phacoemulsification, none of the eyes presented with a pupillary diameter <5 mm, and 61 (85.3%) eyes had a pupillary diameter >6 mm. Conclusion: Preoperative administration of nonsteroidal anti-inflammatory drug and the re-dilation technique resulted in no significant pupil size variation in eyes that were pretreated with the femtosecond laser, when comparing the measurements made before the laser application and at the beginning of phacoemulsification. This approach can avoid the need to proceed with cataract extraction with a constricted pupil.


RESUMO Objetivo: Avaliar a eficácia do uso de anti-inflamatório não-esteróide no pré-operatório e aplicação da técnica de re-dilatação quando necessária para minimizar a variação do tamanho pupilar ao comparar o grau de midríase antes do tra­tamento com laser de femtosegundo no início da facoemulsificação. Métodos: Esse estudo retrospectivo incluiu pacientes que foram submetidos à cirurgia de catarata usando o LenSx (Alcon Laboratories, Inc., Fort Worth, TX). Nosso regime de di­latação de rotina com flurbiprofeno, tropicamida e fenilefrina foi usado. A técnica de re-dilatação doi aplicada em olhos que se manifestaram com um diâmetro pupilar menor do que o diâmetro da capsulotomia programado após o pré-tratamento a laser. A técnica consiste em superar a contração pupilar pela instilação de tropicamida e fenilefrina antes da facoemulsificação. O tamanho pupilar foi avaliado antes da aplicação do laser de femtosegundo e no inicio da facoemulsificação. Resultados: Setenta e cinco olhos (70 pacientes) foram incluídos. Nove (12%) olhos foram submetidos à técnica de re-dilatação. Não houve diferença significativa no diâmetro pupilar médio e na área pupilar média entre os dois tempos cirúrgicos estudados (p=0,412 e 0,437, respectivamente). A constrição global da área pupilar foi de 2,4 mm2. Imediatamente antes de abrir as incisões para a facoemulsificação, nenhum dos olhos apresentava diâmetro pupilar <5 mm e 61 (85,3%) olhos apresentavam um diâmetro pupilar >6 mm. Conclusões: O administração pré-operatória de anti-inflamatório não-esteróide e da técnica de re-dilatação resultaram em uma variação significativa do tamanho pupilar em olhos que foram pré-tratados com laser de femtosegundo, comparando as medidas realizadas antes da aplicação do laser e no inicio da facoemulsificação. Essa abordagem pode evitar a necessidade de prosseguir com a extração da catarata com uma pupila contraída.


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Miosis/prevention & control , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Flurbiprofen/therapeutic use , Phacoemulsification/methods , Lasers , Mydriatics/therapeutic use , Phenylephrine/therapeutic use , Tropicamide/therapeutic use , Miosis/etiology , Miosis/pathology , Pupil/drug effects , Retrospective Studies , Phacoemulsification/adverse effects , Laser Therapy/methods , Intraocular Pressure , Intraoperative Complications/prevention & control
2.
Arq Bras Oftalmol ; 82(2): 111-118, 2019.
Article in English | MEDLINE | ID: mdl-30698231

ABSTRACT

PURPOSE: To assess the efficacy of using a nonste-roidal anti-inflammatory drug preoperatively and of applying the re-dilation technique when necessary to minimize pupil size variation when comparing the degree of mydriasis before femtosecond laser pretreatment with that at the beginning of phacoemulsification. METHODS: This retrospective study included patients who underwent cataract surgery using the LenSx (Alcon Laboratories, Inc., Fort Worth, TX). Our routine dilating regimen with flurbiprofen, tropicamide, and phenylephrine was used. The re-dilation technique was applied on eyes that manifested with a pupillary diameter that was smaller than the programmed capsulotomy diameter after laser pretreatment. The technique consists of overcoming pupillary contraction by instilling tropicamide and phenylephrine before phacoemulsification. Pupil size was assessed before femtosecond laser application and at the beginning of phacoemulsification. RESULTS: Seventy-five eyes (70 patients) were included. Nine (12%) eyes underwent the re-dilation technique. There was no significant difference in mean pupillary diameter and mean pupillary area between the two studied surgical time points (p=0.412 and 0.437, respectively). The overall pupillary area constriction was 2.4 mm2. Immediately before opening the wounds for phacoemulsification, none of the eyes presented with a pupillary diameter <5 mm, and 61 (85.3%) eyes had a pupillary diameter >6 mm. CONCLUSION: Preoperative administration of nonsteroidal anti-inflammatory drug and the re-dilation technique resulted in no significant pupil size variation in eyes that were pretreated with the femtosecond laser, when comparing the measurements made before the laser application and at the beginning of phacoemulsification. This approach can avoid the need to proceed with cataract extraction with a constricted pupil.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Flurbiprofen/therapeutic use , Lasers , Miosis/prevention & control , Mydriatics/therapeutic use , Phacoemulsification/methods , Aged , Aged, 80 and over , Female , Humans , Intraocular Pressure , Intraoperative Complications/prevention & control , Laser Therapy/methods , Male , Middle Aged , Miosis/etiology , Miosis/pathology , Phacoemulsification/adverse effects , Phenylephrine/therapeutic use , Preoperative Period , Pupil/drug effects , Reproducibility of Results , Retrospective Studies , Statistics, Nonparametric , Treatment Outcome , Tropicamide/therapeutic use
3.
Rev. bras. oftalmol ; 76(4): 216-218, July-Aug. 2017. tab, graf
Article in English | LILACS | ID: biblio-899069

ABSTRACT

Abstract We report an unusual case of a 65-year old patient that developed localized bilateral Descemet membrane detachment during non-simultaneous femtosecond laser-assisted cataract surgery (FLACS). The detachment occurred when the laser was performing the secondary incision. In the operating room, the isolate-and-release technique was used to effectively manage this complication. To the best of our knowledge, this is the first reported case of bilateral Descemet membrane detachment during FLACS.


Resumo Relatamos um caso de uma paciente de 65 anos de idade que evoluiu com descolamento de Descemet localizado bilateral durante cirurgias de catarata não simultâneas com laser de femtosegundo. O descolamento ocorreu durante a realização da paracentese pelo laser. Na sala cirúrgica, foi utilizada a técnica de "isolar e liberar" para conduzir eficazmente esta complicação. De acordo com o nosso conhecimento, esse é o primeiro relato de caso de descolamento bilateral da membrana de Descemet durante cirurgia de catarata com laser de femtosegundo.


Subject(s)
Humans , Female , Aged , Rupture , Phacoemulsification/adverse effects , Corneal Diseases/etiology , Descemet Membrane/injuries , Laser Therapy/adverse effects , Phacoemulsification/methods , Corneal Diseases/surgery , Descemet Membrane/surgery , Intraoperative Complications
SELECTION OF CITATIONS
SEARCH DETAIL